NNPC JV Donates $300,000 to Sustain Cancer Treatment at National Hospital, Abuja

In a significant boost to cancer care in Nigeria, the NNPC/Renaissance Joint Venture (JV) has donated $300,000 to the National Hospital, Abuja, to sustain treatment for cancer patients and ensure the continued operation of its advanced radiotherapy equipment.

The donation is targeted at maintaining the hospital’s Linear Accelerator Radiotherapy Machine (LINAC), a high-precision device originally donated by the same JV in 2019. The LINAC has since treated over 2,000 patients, significantly reducing the cost and duration of radiotherapy sessions for cancer patients. While a session previously took about 12 minutes, the machine now delivers treatment in approximately 2 minutes, making care faster and more accessible Officials also highlighted that over 700 indigent patients have benefited from subsidized treatment, with discounts ranging from 25% to full waiver, thanks to the hospital’s partnership with NNPC/Renaissance JV. The fresh funding will support regular maintenance, calibration, and safety compliance of the LINAC, ensuring minimal downtime and uninterrupted treatment services. Hospital authorities emphasized that sustaining such high-tech equipment is vital for improving local cancer-care capacity and reducing the need for patients to seek treatment abroad. The Coordinating Minister of Health and Social Welfare, Muhammed Ali Pate, praised the initiative as “a model corporate intervention” aligning with the government’s commitment to improving healthcare infrastructure and access. Similarly, the hospital’s Chief Medical Director, Muhammad Raji Mahmud, described the donation as “a lifeline of hope” for cancer patients across the country. From the private sector, Tony Attah, managing director of Renaissance Africa Energy Company, stressed that the donation is “a strategic investment in national wellbeing” rather than charity, highlighting the importance of public-private partnerships in addressing critical healthcare needs. While the donation is a welcome boost, healthcare experts note that sustained funding and broader systemic support are essential to ensure long-term access to quality cancer care for Nigerians. The initiative underscores the role of corporate social responsibility in bridging gaps in healthcare delivery and improving patient outcomes nationwide.